The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/22046
StudyName: Eligibility Neoplasm, Unknown Primary NCT00360360
Date of export from the portal: 02.07.2020
Date of Upload / last change: 16.05.2017
License: Creative Commons BY 4.0

----

Description: 
Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site; ODM derived from: https://clinicaltrials.gov/show/NCT00360360
